Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eiko Hirabayashi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Auris, Nasus, Larynx|September 16, 2022
COVID-19 Omicron variant-induced laryngitisYurika Kimura, Eiko Hirabayashi, Mai Yano, et al.
International Forum of Allergy & Rhinology|March 6, 2025
IL-13-Induced Periostin Expression is Increased in Eosinophilic Chronic RhinosinusitisIsao Suzaki, Eiko Hirabayashi, Yuna Teguchi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 23, 2025
Dupilumab achieves clinical remission of comorbid asthma in patients with high-burden eosinophilic chronic rhinosinusitisIsao Suzaki, Akihiko Tanaka, Shota Teguchi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Auris, Nasus, Larynx|September 16, 2022
COVID-19 Omicron variant-induced laryngitisYurika Kimura, Eiko Hirabayashi, Mai Yano, et al.
International Forum of Allergy & Rhinology|March 6, 2025
IL-13-Induced Periostin Expression is Increased in Eosinophilic Chronic RhinosinusitisIsao Suzaki, Eiko Hirabayashi, Yuna Teguchi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 23, 2025
Dupilumab achieves clinical remission of comorbid asthma in patients with high-burden eosinophilic chronic rhinosinusitisIsao Suzaki, Akihiko Tanaka, Shota Teguchi, et al.
Pageof 1